1997
DOI: 10.1016/s0002-8223(97)00235-6
|View full text |Cite
|
Sign up to set email alerts
|

Relationship of Nutritional Status to Length of Stay, Hospital Costs, and Discharge Status of Patients Hospitalized in the Medicine Service

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
151
1
14

Year Published

2000
2000
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 256 publications
(172 citation statements)
references
References 12 publications
6
151
1
14
Order By: Relevance
“…Moreover, poor nutritional status has been implicated in the development and progression of chronic diseases commonly affecting the elderly and leading to complications during hospitalization, poorer clinical outcome and increased mortality (Kagansky et al, 2005). Malnutrition is a predictor of long hospital stay and high mortality in geriatric and cancer patients (Chima et al, 1997;Kagansky et al, 2005).…”
Section: The Pig Model In Human Nutritionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, poor nutritional status has been implicated in the development and progression of chronic diseases commonly affecting the elderly and leading to complications during hospitalization, poorer clinical outcome and increased mortality (Kagansky et al, 2005). Malnutrition is a predictor of long hospital stay and high mortality in geriatric and cancer patients (Chima et al, 1997;Kagansky et al, 2005).…”
Section: The Pig Model In Human Nutritionmentioning
confidence: 99%
“…Moreover, poor nutritional status has been implicated in the development and progression of chronic diseases commonly affecting the elderly and leading to complications during hospitalization, poorer clinical outcome and increased mortality (Kagansky et al, 2005). Malnutrition is a predictor of long hospital stay and high mortality in geriatric and cancer patients (Chima et al, 1997;Kagansky et al, 2005).St-Arnaud-McKenzie et al (2004) suggest that the development of nutritional interventions to maintain hunger and reduce aversion may be necessary to ensure optimal food intake among hospitalized people (cancer patients, geriatric patients, etc.). For instance, Beckoff et al (2001) showed that the use of glucose or other carbohydrate supplements in the diet can increase the total energy intake of older subjects and thus prevent weight loss in the elderly.…”
mentioning
confidence: 99%
“…Reduced dietary intake in the hospitalized elderly is considered a critical risk factor for protein-energy malnutrition (Morley and Silver, 1995;Incalzi et al, 1996;Sullivan et al, 1999;Barton et al, 2000;Kondrup et al, 2002), a condition associated with adverse clinical outcomes (Potter et al, 1995;Chima et al, 1997;Compan et al, 1999;Thomas et al, 2002;Crogan and Pasvogel, 2003;Visvanathan et al, 2004). Ensuring adequate food intake in institutions is contingent on a number of organizational factors (Paquet et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…30,31 The spectrum of CVD in the setting of breast cancer therapy includes congestive heart failure (CHF), myocardial ischemia, hypertension, arrhythmias, QT prolongation, bradycardia, pericarditis, acute coronary syndrome, and thromboembolic events (TEs). [31][32][33][34] Anthracyclines: Doxorubicin and Epirubicin: Anthracyclines bind to the DNA of malignant cells, interfering with the replication process and resulting in cellular death. Anthracycline therapy has been shown to increase the development of CHF and cardiomyopathy by 2%, [34][35][36][37][38][39] doubling to 4% if used in conjunction or sequence with trastuzumab.…”
Section: Chemotherapymentioning
confidence: 99%
“…128,138,143 The most severe complication of trastuzumab therapy has been its potential to adversely affect cardiac function; however, the exact mechanism of its cardiotoxicity remains unclear. 31,144 The risk of trastuzumab-related cardiac events, as with other cardiotoxic agents, increases when additional CVD risk factors are noted, especially a history of coronary artery disease or impaired left ventricular dysfunction. 56, 145 On a positive note, it appears that the cardiotoxic effects of trastuzumab are reversible as long as they are identified early through rigorous monitoring during administration.…”
Section: Targeted Biologic Therapies: Trastuzumab and Lapatinibmentioning
confidence: 99%